Ifg Advisory, LLC Ampio Pharmaceuticals, Inc. Transaction History

Ifg Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$0.16 - $0.47 $1,600 - $4,700	10,000 Added 98.72%	20,130 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $5,672 - $17,322	10,130 New	10,130 $5,000
Q3 2021 Oct 12, 2021	SELL	$1.21 - $1.8 $12,257 - $18,234	-10,130 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$1.56 - $1.98 $15,802 - $20,057	10,130 New	10,130 $16,000
Q1 2021 Apr 19, 2021	SELL	$1.36 - $2.49 $13,776 - $25,223	-10,130 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$0.75 - $2.76 $97 - $358	130 Added 1.3%	10,130 $16,000
Q3 2020 Nov 02, 2020	BUY	$0.61 - $1.17 $6,100 - $11,700	10,000 New	10,000 $9,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.